276 related articles for article (PubMed ID: 30764849)
21. Phase separation ability and phosphatase activity of the SHP1-R360E mutant.
Zhang Q; Kong W; Zhu T; Zhu G; Zhu J; Kong X; Du Y
Biochem Biophys Res Commun; 2022 Apr; 600():150-155. PubMed ID: 35219918
[TBL] [Abstract][Full Text] [Related]
22. Arsenic disulfide synergizes with the phosphoinositide 3-kinase inhibitor PI-103 to eradicate acute myeloid leukemia stem cells by inducing differentiation.
Hong Z; Xiao M; Yang Y; Han Z; Cao Y; Li C; Wu Y; Gong Q; Zhou X; Xu D; Meng L; Ma D; Zhou J
Carcinogenesis; 2011 Oct; 32(10):1550-8. PubMed ID: 21803735
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia.
Heydt Q; Larrue C; Saland E; Bertoli S; Sarry JE; Besson A; Manenti S; Joffre C; Mansat-De Mas V
Oncogene; 2018 Feb; 37(6):787-797. PubMed ID: 29059168
[TBL] [Abstract][Full Text] [Related]
24. CD16
Williams BA; Wang XH; Leyton JV; Maghera S; Deif B; Reilly RM; Minden MD; Keating A
Haematologica; 2018 Oct; 103(10):1720-1729. PubMed ID: 29976748
[TBL] [Abstract][Full Text] [Related]
25. A Novel Glycogen Synthase Kinase-3 Inhibitor Optimized for Acute Myeloid Leukemia Differentiation Activity.
Hu S; Ueda M; Stetson L; Ignatz-Hoover J; Moreton S; Chakrabarti A; Xia Z; Karan G; de Lima M; Agrawal MK; Wald DN
Mol Cancer Ther; 2016 Jul; 15(7):1485-1494. PubMed ID: 27196775
[TBL] [Abstract][Full Text] [Related]
26. Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors.
Xu X; Masubuchi T; Cai Q; Zhao Y; Hui E
Elife; 2021 Nov; 10():. PubMed ID: 34734802
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
[TBL] [Abstract][Full Text] [Related]
28. Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells.
Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
Clin Cancer Res; 2016 Mar; 22(5):1211-21. PubMed ID: 26459180
[TBL] [Abstract][Full Text] [Related]
29. Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model.
Nachliely M; Trachtenberg A; Khalfin B; Nalbandyan K; Cohen-Lahav M; Yasuda K; Sakaki T; Kutner A; Danilenko M
J Steroid Biochem Mol Biol; 2019 Apr; 188():8-16. PubMed ID: 30508646
[TBL] [Abstract][Full Text] [Related]
30. Oroxylin A, a natural compound, mitigates the negative effects of TNFα-treated acute myelogenous leukemia cells.
Li H; Lu N; Yu X; Liu X; Hu P; Zhu Y; Shen L; Xu J; Li Z; Guo Q; Hui H
Carcinogenesis; 2018 Oct; 39(10):1292-1303. PubMed ID: 29346508
[TBL] [Abstract][Full Text] [Related]
31. Z-Ligustilide Selectively Targets AML by Restoring Nuclear Receptors Nur77 and NOR-1-mediated Apoptosis and Differentiation.
Wang C; Liu G; Dou G; Yang Y; Chen L; Ma H; Jiang Z; Ma H; Li C; Li L; Jiang M; Lu Q; Li P; Qi H
Phytomedicine; 2021 Feb; 82():153448. PubMed ID: 33421904
[TBL] [Abstract][Full Text] [Related]
32. Discovery of novel furanylbenzamide inhibitors that target oncogenic tyrosine phosphatase SHP2 in leukemia cells.
Raveendra-Panickar D; Finlay D; Layng FI; Lambert LJ; Celeridad M; Zhao M; Barbosa K; De Backer LJS; Kwong E; Gosalia P; Rodiles S; Holleran J; Ardecky R; Grotegut S; Olson S; Hutchinson JH; Pasquale EB; Vuori K; Deshpande AJ; Cosford NDP; Tautz L
J Biol Chem; 2022 Jan; 298(1):101477. PubMed ID: 34896393
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
34. Protein tyrosine phosphatases, TC-PTP, SHP1, and SHP2, cooperate in rapid dephosphorylation of Stat3 in keratinocytes following UVB irradiation.
Kim DJ; Tremblay ML; Digiovanni J
PLoS One; 2010 Apr; 5(4):e10290. PubMed ID: 20421975
[TBL] [Abstract][Full Text] [Related]
35. A critical role for SHP2 in STAT5 activation and growth factor-mediated proliferation, survival, and differentiation of human CD34+ cells.
Li L; Modi H; McDonald T; Rossi J; Yee JK; Bhatia R
Blood; 2011 Aug; 118(6):1504-15. PubMed ID: 21670473
[TBL] [Abstract][Full Text] [Related]
36. PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2.
Xu X; Hou B; Fulzele A; Masubuchi T; Zhao Y; Wu Z; Hu Y; Jiang Y; Ma Y; Wang H; Bennett EJ; Fu G; Hui E
J Cell Biol; 2020 Jun; 219(6):. PubMed ID: 32437509
[TBL] [Abstract][Full Text] [Related]
37. Suchilactone inhibits the growth of acute myeloid leukaemia by inactivating SHP2.
Wu J; Deng Y; Zhang X; Ma J; Zheng X; Chen Y
Pharm Biol; 2022 Dec; 60(1):144-153. PubMed ID: 34962431
[TBL] [Abstract][Full Text] [Related]
38. ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2.
Walter RB; Raden BW; Zeng R; Häusermann P; Bernstein ID; Cooper JA
J Leukoc Biol; 2008 Jan; 83(1):200-11. PubMed ID: 17947393
[TBL] [Abstract][Full Text] [Related]
39. Polyphyllin D Shows Anticancer Effect through a Selective Inhibition of Src Homology Region 2-Containing Protein Tyrosine Phosphatase-2 (SHP2).
Kwon SJ; Ahn D; Yang HM; Kang HJ; Chung SJ
Molecules; 2021 Feb; 26(4):. PubMed ID: 33562835
[TBL] [Abstract][Full Text] [Related]
40. Reactive oxygen species activate differentiation gene transcription of acute myeloid leukemia cells via the JNK/c-JUN signaling pathway.
Lam CF; Yeung HT; Lam YM; Ng RK
Leuk Res; 2018 May; 68():112-119. PubMed ID: 29609096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
